NCT03253471View on ClinicalTrials.gov

A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

September 18, 2017

Study Completion Date

September 18, 2017

Conditions
Hepatitis C
Interventions
DRUG

AL-611

AL-611 tablets

DRUG

Placebo

Placebo to Match AL-611

Trial Locations (1)

Unknown

SGS Life Sciences, Antwerp

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY

NCT03253471 - A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter